Major Depressive Disorder Treatment in Palm Beach Gardens, FL | Allay Health & Wellness

MDD Treatment in Palm Beach Gardens | Allay Health & Wellness

When antidepressants stop working or never really worked to begin with, it does not mean you are out of options. It means you have not yet found the right option for your biology. Major depressive disorder treatment in Palm Beach Gardens at Allay Health and Wellness is built specifically for that moment: when you have tried what your doctor recommended, waited the required weeks, and still cannot find your way out of the fog.

We offer Spravato (esketamine), the only FDA-approved nasal spray for treatment-resistant depression, alongside off-label IV ketamine infusion therapy, in a licensed, REMS-certified clinic serving Palm Beach County and South Florida. Our clinical team evaluates every adult patient individually, explains every option honestly, and never starts treatment before it is clinically appropriate.

If you are researching major depressive disorder treatment in Palm Beach Gardens because medication has let you down, you are in the right place. This page covers everything you need to make an informed decision.

Understanding Major Depressive Disorder and Treatment-Resistant Depression

Major depressive disorder (MDD) is a clinically recognized mental health condition that affects how a person feels, thinks, and functions in daily life. Common symptoms may include persistent sadness, loss of interest in previously enjoyable activities, changes in sleep or appetite, fatigue, difficulty concentrating, and other emotional or physical challenges that continue for at least two weeks and significantly affect everyday functioning. Because depression can develop differently from one person to another, treatment recommendations are individualized rather than one-size-fits-all.

Some individuals experience treatment-resistant depression (TRD), a term generally used when symptoms do not improve adequately after trying at least two antidepressant medications at appropriate doses and durations under medical supervision. When this occurs, healthcare providers may evaluate other evidence-based treatment options, including therapies that work through different biological pathways than traditional antidepressants. At Allay Health and Wellness, clinicians perform comprehensive evaluations to determine whether advanced treatments, such as Spravato or ketamine-based therapies, may be appropriate based on each patient’s medical history, current symptoms, and clinical guidelines.

Spravato (Esketamine): FDA-Approved, Insurance-Eligible, In-Office

This is the clinical differentiator that sets major depressive disorder treatment in Palm Beach Gardens at Allay apart from most ketamine clinics in South Florida.

Spravato (esketamine) is FDA-approved for two specific indications:

• Treatment-resistant depression in adults, as adjunctive therapy with an oral antidepressant or, following the 2025 FDA monotherapy expansion, as a standalone treatment for qualifying patients
• Depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior

Those are the only two approved indications. Spravato for major depression of the treatment-resistant type is precisely what it was designed and reviewed for. It is not approved for PTSD, bipolar depression, seasonal depression, postpartum depression, anxiety, or chronic pain. Those distinctions are maintained strictly at Allay.

The 2025 monotherapy label expansion is significant for patients who cannot tolerate oral antidepressants or who have experienced adverse reactions across multiple medication trials. Before this update, Spravato required concurrent use of an oral antidepressant. The expanded label now allows qualifying patients to receive Spravato without one. This gives our clinical team meaningful flexibility in designing treatment plans for complex presentations.

How Spravato Works

Esketamine for MDD works on the brain’s glutamate system through NMDA receptor modulation. This is a fundamentally different mechanism from SSRIs and SNRIs. Rather than increasing monoamine availability, esketamine triggers downstream effects that may support synaptogenesis, the formation and strengthening of new synaptic connections involved in mood regulation. Some published research suggests that changes in depressive symptoms may appear earlier in the Spravato treatment course than the four-to-six-week onset typical of oral antidepressants. Individual responses vary, and no specific outcome is guaranteed.

What a Spravato Session Involves

Spravato is a nasal spray that you self-apply under clinical supervision in our Palm Beach Gardens office. It is never dispensed for home use. Every session follows the FDA REMS (Risk Evaluation and Mitigation Strategy) protocol:

• • Each session takes place in our REMS-certified clinical setting
  • A licensed clinician monitors you throughout
  • Blood pressure, heart rate, and oxygen levels are tracked before, during, and after each dose
  • You remain in the clinic for a mandatory minimum two-hour observation period
  • A responsible adult must drive you home; you may not drive on the day of any session

The standard induction schedule is two sessions per week for four weeks, followed by tapering to weekly and then biweekly maintenance based on your clinical response.

IV Ketamine: An Off-Label Alternative for MDD

Ketamine for major depressive disorder via IV infusion is also available at Allay Health and Wellness, and it must be described accurately: it is an off-label use. The FDA has not approved IV ketamine infusions for MDD or any other psychiatric condition. Ketamine’s original and only FDA-approved indication is as an anesthetic. Its use for depression at sub-anesthetic intravenous doses is off-label, legally prescribed and administered by licensed clinicians based on clinical judgment and a growing body of published research, but without specific FDA approval for this indication.

That distinction matters for two reasons. First, patients deserve to know it. Second, it is why antidepressants not working in Florida may lead some patients to Spravato rather than IV ketamine because Spravato carries an FDA-approved pathway and insurance eligibility that IV ketamine generally does not.

IV ketamine acts on the same glutamate and NMDA receptor pathways as esketamine. At Allay, infusions are delivered slowly through an intravenous line in a private, monitored clinical room. A licensed clinician tracks vital signs throughout every session. Sessions last approximately 40 to 60 minutes. A standard initial course involves six infusions over two to three weeks. Candidacy for IV ketamine is determined through the same clinical evaluation process as Spravato.

Risks and Side Effects: What Every Patient Must Know Before Starting

Major depressive disorder treatment in Palm Beach Gardens using Spravato or IV ketamine carries real documented risks. Full disclosure before treatment begins is a clinical and ethical obligation at Allay Health and Wellness. When you are exploring innovative therapies for severe depression, feeling fully informed is just as important as feeling hopeful. Both Spravato and intravenous ketamine offer powerful new paths forward, yet they also require a clear understanding of what happens during and after each session. From temporary dissociation and sedation to brief shifts in blood pressure, knowing these effects allows you to prepare with confidence. At our clinic, transparency is the foundation of compassionate care. We prioritize your safety by providing comprehensive evaluations, constant clinical supervision, and honest conversations about every aspect of your care plan. Understanding these potential risks ensures that your path toward healing remains safe, supportive, and tailored to your unique health profile.

• Dissociation: A temporary altered state involving changes in how you perceive time, space, or self. This is an expected and well-documented effect of both treatments at therapeutic doses. It is monitored by clinical staff throughout every session and typically resolves before discharge.
• Sedation: Both treatments produce sedation. You may not drive on the day of any session. A responsible adult must arrange transportation home after every appointment without exception.
• Blood pressure changes: Temporary increases in blood pressure are common during both Spravato and IV ketamine sessions. Vital signs are checked before, during, and after every session.
• Nausea and dizziness: Generally mild and typically resolving within the post-session observation window.
• Psychological effects during sessions: Some patients experience anxiety, unusual perceptions, or heightened emotional responses. Clinical staff are present throughout every session and are trained to provide immediate support.
• Controlled substance status: Ketamine is a Schedule III controlled substance under federal law. Dependency risk at supervised therapeutic doses is considered low but is not zero. Patients with substance use histories are evaluated carefully; this does not automatically disqualify someone, but it is a clinically significant factor that shapes the recommendation.
• Age-specific considerations: Older adults may experience heightened sensitivity to blood pressure effects, increased fall risk related to sedation or dissociation, polypharmacy interactions, and cognitive effects. These are reviewed individually during intake.

No specific outcome from major depressive disorder treatment in Palm Beach Gardens at Allay is guaranteed. Individual responses vary. Every patient undergoes a thorough risk assessment before any treatment begins.

What to Expect at Allay Health and Wellness

Choosing major depressive disorder treatment in Palm Beach Gardens begins with a thoughtful clinical evaluation rather than an immediate treatment recommendation. At Allay Health and Wellness, every patient’s care starts with a complimentary consultation where the team discusses symptoms, previous treatments, and answers questions in a supportive, educational setting.

Patients who move forward receive a comprehensive psychiatric evaluation that reviews their diagnosis, antidepressant history, medication doses and durations, current prescriptions, cardiovascular health, psychiatric history, including any history of psychosis or mania, and substance use history. Before treatment begins, clinicians explain the differences between IV ketamine and FDA-approved Spravato, including their indications, potential risks, monitoring requirements, and realistic expectations so patients can provide informed consent.

Throughout major depressive disorder treatment in Palm Beach Gardens, licensed clinicians monitor vital signs, evaluate clinical progress using standardized assessment tools, and adjust care when appropriate. Coordination with psychiatrists, therapists, and primary care providers supports continuity of care. Our clinical team includes Katy Redfield, APRN, Nicholas Marino, MBA, Roland Verfaillie, Ph.D., and Daniel Cartledge, M.D., bringing extensive mental health and clinical experience to patient care.

Insurance and Cost: Depression Treatment Covered by Insurance in Florida

The insurance advantage of major depressive disorder treatment in Palm Beach Gardens at Allay is one of the most practical reasons patients choose our clinic over cash-pay-only providers. Because Spravato carries FDA approval for treatment-resistant depression, it is eligible for insurance coverage consideration in a way that off-label IV ketamine is not. Allay Health and Wellness currently accepts:

• Medicare: Part B may cover esketamine for MDD in Palm Beach County when TRD criteria are documented and medically necessary. This is the strongest coverage pathway for seniors and the largest patient segment in Palm Beach County.
• Cigna
• United Healthcare
• Aetna

Coverage is never guaranteed. It depends on your individual plan, your diagnosis documentation, and whether prior authorization criteria are met. Our team manages preauthorization, benefit verification, and appeals on your behalf. We provide a clear cost summary before any sessions are scheduled.

Off-label IV ketamine for MDD is generally not covered by most insurance plans. If you are asking whether depression treatment covered by insurance in Florida is available to you specifically, our team will verify your benefits at no cost before any commitment is made. Coverage may apply; verify with your provider.

Am I a Candidate for Major Depressive Disorder Treatment in Palm Beach Gardens?

Finding the right treatment begins with an accurate diagnosis, not assumptions. Every patient receives a comprehensive clinical evaluation to determine whether major depressive disorder treatment in Palm Beach Gardens is appropriate based on medical history, previous treatments, current symptoms, and overall health before any recommendations are made.

Adults who may be appropriate candidates typically include those who have:

• A formal MDD diagnosis from a licensed clinician
• A documented history of inadequate response to at least two antidepressants at adequate doses and durations
• No specific medical contraindications such as uncontrolled hypertension, active psychosis, or history of aneurysmal vascular disease
• For Spravato: willingness to use an oral antidepressant alongside treatment (required under the pre-2025 indication; now optional for qualifying patients under the 2025 monotherapy expansion)
• Substance use history is evaluated carefully and does not automatically disqualify a candidate

Allay Health and Wellness evaluates and treats adults 18 years of age and older. Every treatment recommendation is individualized and made by a licensed healthcare provider after a comprehensive assessment.

If you are considering major depressive disorder treatment in Palm Beach Gardens or wondering whether an evaluation is appropriate for your situation, a consultation is the first step. The depression doctor will review your history, answer your questions, and discuss appropriate treatment options based on your individual needs before any treatment decisions are made.

FAQs about Major Depressive Disorder Treatment in Palm Beach Gardens

Q1. What makes Allay Health and Wellness different for treating major depressive disorder?
Allay Health and Wellness offers Spravato and IV ketamine therapy after comprehensive evaluations. Treatment recommendations are individualized, medically supervised, and based on each patient’s diagnosis, treatment history, and clinical needs.

Q2. What is the difference between Spravato and IV ketamine?
Spravato is an FDA-approved esketamine nasal spray for certain adults with treatment-resistant depression. IV ketamine is an off-label intravenous treatment. Your provider determines which option may be appropriate.

Q3. What should I do if antidepressants are not improving my depression?
Schedule a comprehensive medical evaluation. Bring your medication history and previous treatment records so clinicians can assess your condition and discuss whether advanced treatment options may be appropriate.

Q4. Does insurance cover Spravato treatment?
Some Medicare, Cigna, UnitedHealthcare, and Aetna plans may provide coverage when medical-necessity criteria are met. Coverage depends on individual policies and prior authorization requirements.

Q5. Does insurance cover IV ketamine?
Many insurance plans do not cover IV ketamine for depression because it is considered an off label treatment. Patients should verify benefits directly with their insurance provider before treatment.

Q6. How many Spravato treatment sessions will I need?
Treatment frequency varies according to your diagnosis, clinical response, and healthcare provider’s recommendations. Your treatment plan is individualized after a comprehensive medical evaluation and ongoing progress assessments.

Q7. Can older adults receive Spravato therapy?
Older adults may be eligible following a medical evaluation. Clinicians carefully assess medical history, medications, blood pressure, and overall health before recommending treatment.

Q8. Do I need a referral before scheduling a consultation?
A referral is not always required. Patients should bring medical records, medication history, and relevant mental health documentation to support a thorough clinical evaluation.

Q9. What is esketamine?
Esketamine is the active ingredient in Spravato, an FDA-approved prescription nasal spray for certain adults with treatment-resistant depression administered under medical supervision in certified healthcare settings.

Q10. How do I know if Spravato treatment may be right for me?
The best way to determine eligibility is through a consultation. A healthcare provider reviews your diagnosis, symptoms, medical history, and previous treatments before recommending appropriate care.

Schedule a Free Assessment for Major Depressive Disorder Treatment in Palm Beach Gardens

If standard antidepressants have not provided the relief you need and you want to speak with a licensed clinical team that will evaluate your situation honestly, Allay Health and Wellness is ready to help you take the next step.

This is not a pressure consultation. Our team will review your history, answer your questions, verify your insurance benefits, and tell you clearly whether major depressive disorder treatment in Palm Beach Gardens at our clinic may be appropriate for your situation before you make any commitment.

Address: 11000 Prosperity Farms Rd, Suite 101, Palm Beach Gardens, FL 33410
Email: [email protected]
Phone: (561) 421-6444

Contact our Allay Health and Wellness office directly. We serve patients from Palm Beach Gardens, West Palm Beach, Jupiter, North Palm Beach, Riviera Beach, Royal Palm Beach, Lake Park, Palm Springs, Juno Beach, Boca Raton, Delray Beach, Deerfield Beach, Stuart, and communities across Palm Beach and Broward Counties.

Medical Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Spravato (esketamine) is FDA-approved for treatment-resistant depression as adjunctive therapy with an oral antidepressant or, following the 2025 monotherapy expansion, as standalone therapy for qualifying patients and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It is not approved for PTSD, bipolar depression, seasonal depression, postpartum depression, chronic pain, anxiety, or any other condition. IV ketamine infusion therapy for major depressive disorder is an off-label use of ketamine and has not been specifically approved by the FDA for this condition. Individual treatment outcomes vary and are not guaranteed. All treatments at Allay Health and Wellness are provided only after evaluation and approval by a licensed clinician. Allay treats adult patients 18 years and older exclusively. Ketamine is a Schedule III controlled substance administered exclusively under medical supervision in a licensed clinical setting. Spravato is available only through certified healthcare settings under the FDA REMS program. Viewing this page does not establish a provider-patient relationship.

Reviewed by Nicholas Marino, MBA, Co-Founder and CEO, Allay Health and Wellness